Page 231 - Read Online
P. 231

Shibata                                                                              Living donor liver transplantation anastomotic stenosis interventional radiology balloon dilatation

                                                              in  patients  with  reduced-size  liver  transplantation  or
            A                        B
                                                              LDLT,  the  rate  of  PV  complication  can  be  higher  (9-
                                                              14%) than in patients with conventional deceased donor
                                                              liver transplantation [7,15] . PV complications are divided
                                                              mainly into anastomotic PVS and portal vein thrombosis
                                                              (PVT) [16] . Anastomotic PVS can lead to graft failure if
                                                              not  properly  treated.  The  treatment  options  for  PVS
                                                              after liver  transplantation are  surgical  treatment and
                                                              percutaneous  interventions,  including  percutaneous
                                                              balloon  dilatation  and  stent  placement.  However,
            C                        D                        surgical  treatment  of  these  complications  has  been
                                                              limited  owing  to  technical  difficulties  or  invasiveness.
                                                              Currently,  the  surgical  treatment  of  PVS  after  liver
                                                              transplantation has been replaced by percutaneous
                                                              balloon  dilatation  and  stent placement, because  of
                                                              lower invasiveness and greater effectiveness.

                                                              PVS  was  clinically  suspected  with  the  following
                                                              findings: (1) clinical symptoms of portal hypertension,
                                                              such as ascites, splenomegaly, gastrointestinal tract
           Figure 2:  A 1-year-old girl with biliary atresia underwent left-lobe
           LDLT, HVOO repeated after 3-sessions of balloon dilatation, and   bleeding from varices, and thrombocytopenia; and (2)
           stent placement was performed. (A) preoperative hepatic venogram   US findings, including greater than 50% stenosis (the
           showing an anastomotic stricture; (B) fluoroscopic view after
           stent placement. However, HVOO repeated, and additional stent   diameter of stenosis/the diameter of a main PV on the
           placement was performed twice. After the 3rd stent placement, HV   mesenteric side) or no flow in the PV; or the presence
           was patent, and no HVOO was noted for 5 years. (C) fluoroscopic   of  an  acceleration  of  flow  at  the  stenosis  or  a  post-
           view the 3rd after stent placement; (D) hepatic venogram showing
           no anastomotic stricture. LDLT: living donor liver transplantation;   stenotic jet flow or minimal flow in the intrahepatic PV
           HVOO: hepatic venous outflow obstruction           on  Doppler  US.  Our  inclusion  criteria  for  PVS  were:
                                                              (1) greater than 50% stenosis (the diameter of the
                                                              stenosis/the  diameter  of  a  PV  on  the  distal  side);  or
           (98%). The primary and primary assisted patency at 1,   (2) > 5 mmHg pressure gradient across the stenosis
           3, 5, 10 years after the initial privacy threshold analysis   between the proximal and distal PV.
           (PTA) were 64%, 57%, 57%, 52% and 98%, 95%, 95%,
           and 95% respectively.                              Procedures

                                                              The approach to the intrahepatic PV is transhepatic at
           IR FOR PVS                                         the first session of percutaneous intervention. Balloon
                                                              dilatation [Figure 3] is performed following portography
           The rate of PV complications after deceased donor liver   with a 7.0-Fr percutaneous transluminal angioplasty
           transplantation has been reported to be < 3% . However,   catheter with a balloon diameter of 6-12 mm. The balloon
                                                 [7]
                   A                             B                          C















           Figure 3: A 7-year-old girl with biliary atresia underwent left-lobe LDLT, PVS was suspected 5 years after LDLT, and portography was
           performed. (A) pretreatment portogram showing an anastomotic stricture (arrow), collateral vessels (arrowhead), and poor flow through the
           intrahepatic portal vein; (B) fluoroscopic view during balloon angioplasty showing the notch of the balloon at the stenosis; (C) portogram
           after the balloon angioplasty showing improved blood flow through the portal vein and disappearance of collateral vessels. PVS did not
           recur after the balloon angioplasty; LDLT: living donor liver transplantation; PVS: portal venous stenosis


                           Hepatoma Research ¦ Volume 3 ¦ October 25, 2017                                223
   226   227   228   229   230   231   232   233   234   235   236